DDJ Patient Article · As of March 2026 · Explained Simply
How does the treatment of Periodontitis Stage I to III proceed step-by-step, and at what points does the clinical logic change?
Explained clearly based on current scientific studies. This article helps you make informed decisions with your dentist.
This article is about a treatment your dentist may recommend or perform.
Quick and Clear
The most important findings at a glance:
- Research overall shows a benefit.
- The scientific basis is good. Several high-quality studies yield similar results.
- It is important to clearly distinguish between diagnosis, motivation, and mechanical therapy.
- For gum disease (periodontitis), the best therapy is not just the first measure alone, but a cleanly managed transition between steps.
Why is this topic important to me?
You may have heard that there are differing opinions on this topic. This is because science is often more complex than a simple yes or no answer suggests. In this article, we explain what current research actually shows—without technical jargon and without omitting important details.
It is important to explain the treatment phases, not just whether scaling and root planing (SRP) can help.
Why is this important to you? Because as a patient, you can make better decisions when you understand the background. This article does not replace a conversation with your dentist, but it gives you the knowledge to ask the right questions.
In research, the most important questions revolve around the following areas: Diagnosis and Initial Phase, Non-surgical Therapy and Reevaluation, Escalation, and Long-term Care. For each of these areas, we explain below what the studies say and what that means for your daily life.
What does "Diagnosis and Initial Phase" mean for me as a patient?
A common patient question is how to weigh diagnosis and initial phase. The answer is not as simple as one might hope—but research now provides clear indications.
The scientific evidence for the diagnosis and initial phase of periodontitis treatment is based on a broad foundation of systematic reviews and summaries of multiple studies. The current body of research consistently shows that a structured examination with a complete periodontal status forms the basis of any stage-appropriate therapy. Without this initial diagnosis, neither the severity of the disease can be reliably classified nor the treatment path meaningfully planned. Systematic reviews, such as one by So et al. (2023) on salivary protein composition in gum disease (periodontitis), underline that biomarkers could play a supplementary role in the future, but they do not replace clinical examination at this time.
The initial phase includes, according to current consensus, patient education, oral hygiene instruction, and the removal of plaque-retentive factors. Several of the included summaries of multiple studies—including the work on adjunctive interventions in non-surgical periodontitis therapy (Jpn Dent Sci Rev, 2025) and the systematic review on antimicrobial adjunct therapy (J Pharm Bioallied Sci, 2025)—confirm that mechanical plaque control constitutes the therapeutic core of this phase. The body of research supports a clear benefit of professional instruction, even if the effect sizes vary between studies.
The consistency of findings across nine systematic reviews and summaries of multiple studies—all assessed with high evidence weighting and low risk of bias—gives the statement on the effectiveness of the initial phase a solid foundation. The research landscape includes both works with a narrow focus on non-surgical therapy and those investigating adjunctive procedures like povidone-iodine rinses (According to Slugovc-Moravia et al., 2009) or photodynamic therapy (From et al., 2022) in the initial phase.
Methodologically, it should be noted that most primary studies included in the reviews involve heterogeneous populations and define the intensity of the initial phase differently across studies. This does not limit the direction of the signal—the benefit of a structured initial phase is robustly proven—but rather the precision of individual effect estimates. In particular, the question of which combination of instruction, professional cleaning, and risk adjustment is optimal in an individual case remains clinically open.
Methodologically, it should be noted that the included studies vary significantly in study design, follow-up period, and population selection. This heterogeneity limits the comparability of results and explains why pooled effect estimates must be interpreted with caution. Nevertheless, the direction of the effect is consistent across different types of studies.
For transferability to the German-speaking care context, it is also relevant that a significant portion of the scientific evidence originates from Anglo-American or Scandinavian healthcare systems. Differences in reimbursement structure, treatment culture, and patient access can influence effect sizes without invalidating the basic statement.
For the practice, this means: It is important to clearly distinguish between diagnosis, motivation, and mechanical therapy. The initial phase is not an optional entry point but a prerequisite for any further treatment decision. Without a thorough assessment of findings, the treatment process lacks its clinical staging.
Clinical decisions should not be based on single studies but on the overall direction of available scientific evidence. In the case of the initial phase, this direction is clear: Structured diagnostics and consistent cause-based therapy drive the treatment. Skipping or abbreviating this phase is not supported by the current research.
What is important here: A well-supported benefit of the initial phase does not mean that all patients respond equally. The scientific evidence shows the benefit on average—the individual adjustment based on risk profile, compliance, and severity remains the dentist's responsibility.
What does this mean for your next dental visit? The research findings help you better understand your dentist's recommendations and ask targeted questions if anything is unclear.
Science has intensively investigated this topic in recent years. For this article, more than 9 scientific papers were evaluated. It is important to understand that not every study has the same level of evidence. Large, well-controlled investigations provide more reliable results than small observational studies. The overall picture from these various studies is what we present to you here.
💡 What does this mean for you?
It is important to clearly distinguish between diagnosis, motivation, and mechanical therapy. Discuss this with your dentist at your next visit what this specifically means for your situation.
What does "Non-Surgical Therapy and Reevaluation" mean for me as a patient?
When it comes to non-surgical therapy and reevaluation, the research situation is clearer than many people think. Here you will learn what current studies really show.
Non-surgical periodontitis therapy—at its core, subgingival scaling and root planing (SRP)—is the best-studied step in treating Stage I to III. Several of the included systematic reviews deal directly with the efficacy of this intervention and its adjunctive extensions. The work from the Japanese Dental Science Review (2025) shows that adjunctive procedures for Stage III/IV can improve the effect of non-surgical therapy alone in certain parameters, while the basic effectiveness of SRP remains stable as a reference.
The systematic review on adjunctive antimicrobial therapy (J Pharm Bioallied Sci, 2025) confirms that combining mechanical therapy with antimicrobial support can improve clinical outcomes—especially regarding probing depths and clinical attachment level. In parallel, the systematic review of photodynamic therapy for molar-incisor periodontal disease (From et al., 2022) shows that light-based adjuvants can also allow for additional attachment gain, although the clinical relevance of this added benefit depends on the initial condition.
A central finding from the literature is the importance of reevaluation after the non-surgical phase. The work on povidone-iodine rinsing during non-surgical therapy (Slugovc-Moravia et al., 2009) and the review on the timing of systemic antibiotics (Aravena et al., 2015) suggest that treatment success can only be reliably assessed after a defined healing phase. Without reevaluation, there is a risk that the condition will either escalate unnecessarily or be insufficiently treated. Therefore, reevaluation is not an administrative step but a clinical decision point.
For this cluster, all nine sources are relevant, including five systematic reviews and four scientific review articles. All sources were classified as methodologically sound (green) and with high evidence weight. The consistency of the beneficial direction across various study designs and questions significantly strengthens the overall statement. Nevertheless, the reported effect sizes vary between studies, which limits the precision of individual recommendations.
Additionally, studies on systemic endpoints—such as the summary of multiple studies on the effect of non-surgical periodontal therapy on kidney function in patients with chronic kidney disease (Zhang et al., 2019) and the review on systemic inflammation in hemodialysis patients (Zhang et al., 2020)—show that non-surgical therapy positively influences systemic markers beyond just the periodontal findings. Although these studies have a narrower scope (systemic endpoints rather than direct paro outcomes) and moderate generalizability, they support the overall message: Non-surgical therapy works, and not only locally.
Methodologically, it must be noted that the included studies vary significantly in study design, follow-up period, and population selection. This heterogeneity limits the comparability of the results and explains why pooled effect estimates must be interpreted with caution. Nevertheless, the direction of the effect is consistent across various study types.
For generalizability to the German-speaking care context, it is also relevant that a significant portion of the scientific evidence comes from Anglo-American or Scandinavian healthcare systems. Differences in reimbursement structure, treatment culture, and patient access can influence effect sizes without invalidating the basic statement.
For practice, this means: It is important to treat reevaluation as a decision point, not a formality. After non-surgical therapy, it is determined whether the basic treatment has been sufficiently maintained or if an escalation is necessary. This transition is the most clinically relevant moment in the treatment pathway.
The clinical decision after reevaluation should be guided by the overall trend of the scientific evidence, not by a single probing depth measurement. The body of literature shows: Non-surgical therapy works in most cases for Stage I to III, but not for all patients and not equally at all sites. Residual problems after initial therapy are not treatment failure, but the starting point for the next decision.
At the same time, the broad scientific basis for SRP and adjunctive procedures must not obscure the fact that individual therapy response depends on factors that are only limitedly represented in the studies—such as smoking status, compliance, systemic diseases, and defect morphology.
What does this mean for your next dental visit? The research findings help you better contextualize your dentist's recommendations and ask targeted questions if anything is unclear.
How do scientists arrive at these conclusions? They don't just evaluate a single study; they look at many investigations simultaneously. This allows them to determine whether a result was random or if it is consistently confirmed. In this case, the findings are based on 9 scientific works from different countries and research groups.
💡 What does this mean for you?
It is important to treat reevaluation as a decision point. Discuss this with your dentist at your next visit what this specifically means for your situation.
What does "escalation and long-term maintenance" mean for me as a patient?
One point that often causes uncertainty is escalation and long-term maintenance. However, science has made important advances in recent years.
The scientific evidence for escalation after insufficient therapeutic response and for long-term supportive periodontal therapy (SPT) is based on the totality of included reviews, which consistently show that Stage I to III is not a one-step model. Persistent probing depths, progressive loss of tooth support, or recurring signs of inflammation after reevaluation can justify further non-surgical or surgical steps. The systematic review on the efficacy of minimally invasive non-surgical therapy (MINST) in Stage III/IV (Swiss Dent J, 2025) shows that even with advanced disease, non-surgical approaches can remain effective—albeit with a decreasing success rate as severity increases.
The question of when surgery should be escalated is not addressed in the literature provided in isolation, but within the context of the entire treatment pathway. The summary of multiple studies on adjunctive interventions (Jpn Dent Sci Rev, 2025) and the review on antimicrobial adjunct therapy (J Pharm Bioallied Sci, 2025) suggest that adjunctive procedures can raise the threshold for escalation—meaning more patients can be stabilized during the non-surgical phase. This shifts the decision point but does not eliminate it.
For long-term care, scientific evidence shows a clear benefit to structured periodontal maintenance (PM). The studies on the systemic effects of non-surgical therapy (Zhang et al., 2019; Zhang et al., 2020) emphasize that therapeutic effects—both local and systemic—do not remain stable permanently without regular follow-up care. In the scientific evidence, PM is not an optional extension of treatment but an integral part of it. The interval and intensity of follow-up care must be adapted to the individual risk profile.
An overview of nine systematic reviews and a summary of multiple studies—all rated with Evidence Level A, strong conclusion, and direction of benefit—yields a consistent picture: Periodontitis treatment Stage I to III is a staged process whose success does not depend solely on the first step of therapy but on the smooth management of transitions between phases. The scientific evidence for the benefit of non-surgical initial therapy is strong; the scientific evidence for the added benefit of adjunctive procedures is positive but variable in effect size; and the scientific evidence for the necessity of long-term care is clear.
Methodologically, it should be noted that the included studies vary significantly in study design, follow-up period, and population selection. This heterogeneity limits the comparability of results and explains why pooled effect estimates must be interpreted with caution. Nevertheless, the direction of the effect is consistent across different study types.
For transferability to the German-speaking care context, it is also relevant that a significant portion of the scientific evidence originates from Anglo-American or Scandinavian healthcare systems. Differences in reimbursement structure, treatment culture, and patient access can influence effect sizes without invalidating the core statement.
For practice, this means: Supportive follow-up care is part of the treatment and not just an addendum to the treatment plan. The scientific evidence clearly shows that without PM, the treatment success achieved during the active phase cannot be maintained permanently. The clinical challenge lies less in the question of whether follow-up should occur, but rather in how intensive and at what interval.
The decision for surgical escalation after insufficient therapeutic response should be based on reevaluation, not on a rigid algorithm. The scientific evidence supports a stepwise approach where non-surgical options, including adjunctive procedures, are exhausted first. Only in cases of persistent deep pockets or progressive loss of tooth support despite adequate initial therapy is the surgical option supported by the scientific evidence.
The clinical decision should be guided not by individual studies, but by the overall direction of available scientific evidence. In the case of periodontitis treatment Stage I to III, this direction is clear: the treatment pathway is staged, the transitions are clinically manageable, and long-term care is not an appendix but a component of the treatment.
What does this mean for you? Supportive care is part of the treatment and not just an addendum.
What does this mean for your next dental visit? The research findings help you better place your dentist's recommendations and ask targeted questions if anything is unclear.
What makes these results reliable? In medical research, the more independent studies that arrive at the same result, the more certain the statement is. The type of study and the number of participants also play an important role. Large controlled studies with many participants provide more reliable results than small surveys.
💡 What does this mean for you?
Supportive care is part of the treatment and not just an addendum. Discuss this with your dentist at your next visit what this specifically means for your situation.
Frequently Asked Questions
Here we answer the questions patients most frequently ask about this topic:
❓ What does "Diagnostics and Initial Phase" mean for me as a patient?
The cause therapy and instruction form the first clinical core. It is important to clearly distinguish between diagnosis, motivation, and mechanical therapy.
❓ What does "Non-surgical Therapy and Reevaluation" mean for me as a patient?
Reevaluation determines whether the initial therapy has been sufficiently maintained. It is important to treat reevaluation as a decision point.
❓ What does "Escalation and Long-term Care" mean for me as a patient?
Persistent deficits can warrant further non-surgical or surgical steps. Supportive care is part of the treatment and not just for follow-up.
❓ How certain are the results?
The scientific basis is good. Several high-quality studies yield similar results.
❓ Should I change my behavior based on this information?
Speak with your dentist before making any changes. This article informs you about the state of research, but every situation is individual. Your dentist knows your personal health status best.
❓ Where can I learn more?
The detailed professional version of this article, with all study details, can be found on Daily Dental Journal. For personal advice, consult your dentist.
❓ What is the most important message of this article?
Periodontitis therapy Stage I to III is a staged process involving diagnosis, cause therapy, reevaluation, and potentially escalation.
❓ Why are there differing opinions on this topic?
The conflict lies between a schematic procedure and a truly stage- and reevaluation-based therapy.
🦷 When Should You See a Dentist?
Schedule an appointment with your dentist if:
- You are unsure if a recommended treatment is right for you
- You have symptoms or notice changes
- You would like a second opinion
- You have questions about the topics described in this article
- It has been more than a year since your last dental visit
Important: This article does not replace a dentist visit. It helps you go into the conversation informed.
What You Can Do Yourself
Here are concrete steps you can take as a patient:
The Most Important Thing in One Sentence
In periodontal disease (periodontitis), the best therapy is not the initial measure alone, but a cleanly managed transition between steps.
Note on Source Material
This article is based on the DDJ Expert Article and current scientific evidence. All statements are supported by studies fully cited in the expert article.
The content has been adapted for patients by the DDJ editorial team. Medical decisions should always be made in consultation with your dentist.
Date: March 2026 · Language: American English (en-US) · Target Audience: Patients and interested laypersons